| Tag | Content |
|---|
EnhancerAtlas ID | HS041-11925 |
Organism | Homo sapiens |
Tissue/cell | EWS502 |
Coordinate | chr2:152622060-152624230 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr2:152622240-152622258 | CTCTCCATCCTTCCCTCC | - | 6.24 | | FOXC1 | MA0032.2 | chr2:152623111-152623122 | TAAGTAAACAT | + | 6.02 | | Foxa2 | MA0047.2 | chr2:152623109-152623121 | ACTAAGTAAACA | - | 6.44 | | ZNF263 | MA0528.1 | chr2:152622243-152622264 | TCCATCCTTCCCTCCTCCTCA | - | 6.29 | | ZNF263 | MA0528.1 | chr2:152622240-152622261 | CTCTCCATCCTTCCCTCCTCC | - | 7.43 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_10660 | chr2:152620979-152629724 | CD19_Primary | | SE_11651 | chr2:152618651-152633942 | CD20 | | SE_40477 | chr2:152622452-152625492 | K562 | | SE_51329 | chr2:152622757-152625241 | Skeletal_Muscle |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 152622339 | 152623366 | | chr2 | 152623896 | 152624170 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I151765 | chr2 | 152622469 | 152624810 |
|
Enhancer Sequence | TTCTAACTCC AGGAGAAAAT ACAAGGGAAA AGGGAAAAGT GGAGGAAATA GGGCTTATCT 60
CCTTCTTCTA AATAGTGACT TCAGAGCTTG GAAATACAAG ATGAACTGGA ATGCATGCCC 120
TTTCCTGCCT CTTTCCGCTG CCATCAACTC CACATGCTCT CCAAGAAGCC CTGCCAGACC 180
CTCTCCATCC TTCCCTCCTC CTCACCCCAA CCTCCGGGTT CCACCCTTCA GTGTCAAAAC 240
CACCACCACC ACCACCACAG AGTGGGGAAG GAGATGGGAG GAGCAGTGTT TTAACCTGCT 300
GCACATGGAC TGAAATACAG CTCTGAAGGC GGAAATAAAA ACAAAGCCCT CCCATTAGAA 360
TGAAATCCAA TCTCCTTGCC TCAGGCCCAC TTCCTGCCCC TCCGTGCTCA GGCCACACTC 420
TGGACTCACT GCCTCAAGTG CTTAAGCTCC CTGCTCAAAC AGCGCCTGCC CATCGCTCTC 480
CACGCCCCTG CCTCGCTGTA TTGCCGTATT GCCTGCATGC TGCTCATCAC CTCTACCTTC 540
CGTTGTAGAG CTGTCTATCT GGGTGTGACC TGACCTCTCC CAGGGGGAAC GGGCTGCTAA 600
GAGTTGGGAC TGCAGGGGCT TGTTTCATGC TGTGAATTAG TTCCTGGCAT GCAGAAGGTA 660
CACACAAAAA CAAATGAGAA CAGAAGTTTG AGTAGCATAA TACACTAGAA ATTACTTCTT 720
ATTTATGGTA TTCATTTTAG ACATGGAGAA AATGAGGCCT AGAAAGGTTA GAGTGGCTTC 780
CCCAAAGCCA CATGACCAGG GAGCAGTGGG GTCAGGCCTA GAAGTCCAGG GGTCCTGATT 840
CTTCCAGACT GGTGTTCATC CAAACACCCC ACCCTCACCC ACAGTGGCCT TTGGTGTGTT 900
CTCTCTGTGT CTCTCTCATG CACACACACA CACACACACA CACTCCTTCT AATGGGCCAC 960
AAGGGAAATC TCAAGTAAAT GATATTCAGT AGTAGTTTCC TGCCCCAACA TTCAAAATTT 1020
GAGCCAAGAG AGAAAGGAAG TTGAGAGCTA CTAAGTAAAC ATTTAAAGCC TACAAGGCAG 1080
AGATCTTCTC CAAATTTGAC AGATAAAGCA CTGGGCCTTG AAGAAGCAGA GAAGGTAAGA 1140
GGCTTTGCTC AGTAGCTCCA CCAACAAGCT GCGTTGCTGA CTCAGAGCCC TTTGTCATAA 1200
CAGCACTGCT GGGCCCCTCA TTAGACTGCC TGCACCAAGG CTGAGGTCTC CTGTTGGTTG 1260
TCCCCATCTC TGGTGGATGC CCTTGTGACT GCATGACCTA CAGTCTCTCA AGTTCTTAAC 1320
AAGCCACATC GGCTTTGGGG CAGCAGCCCT ACCTTTGATT CAGAGCTTAG GGTGTGTGCC 1380
TTCGAGGCTG AGAGGAGTGT GCAGGCATAG CTGGCACTTT CTAGAATGAC AGCTCATCTG 1440
CCTGCCCACC CCCCCGTGAA GGTGCCAGGG ACTGAGATAA CCCAAAGGCA CTCACCCTCC 1500
CAGGAGTACC TCTCATCCTC CCCTGTGCAT TAGCTCCTAG GGTCAGTGGA TGCTCCCAGC 1560
TAGAGATTAC TGGGCAAAGC CACCTTTAAA ATGAACAAAC TTGCACATAT AGTTCCCCCA 1620
GCTACTCAGG AGGCTGACGC AGGAGGATCA CTTGAACCCA GGAGTTGGAG TCCAGCATGG 1680
GCAACATGGC AGGTGAGACC CCCATCTCTA AAAAACAAAA AAGAAAAGAA AAATCAATGA 1740
GCCCAGCTAG CACTTAGCAA GTGTGGGCAT AAACATGCAT GTTCAATGTT CAAGCACCAG 1800
AGGACACACA CGAACACCCC TCACAGTTTT ATTTTAGGTC AGAAGTAGGC AACCTTAGAG 1860
TTGGAACTTG GAAACAGGCA TATGTTAGTG TCATACAGAG GACAGATGAG ACAGAATCTG 1920
AGGGCCTCCA CAGGGCAGAA TGAGGCTTAA GAGAGTTCCA GGGAAGTTAA TACAGAGAAA 1980
GACTTCCTAA CAACTAGAGC TGCCTGAAAA AGCAGCAGCC TGTCTGGCAC GGCAGTGGCT 2040
GCTGTGGCTC AAAGGGTATG GAACATGAAT GCACAGCCCC TGAGTAGAAA CGCTGAGGGG 2100
ACTTCAGCCT CCAGGATCCT TCCAACACTA AGACTCTGAG ACATCTTGAA ATAGTTCACT 2160
TACTGCTGTC 2170
|
